A study of 20 patient volunteers conducted by Shawn B. Allen, MD, and Neil A. Goldenberg, MD, PhD, found that reconstitution of abobotulinumtoxinA with preserved saline results in significantly less pain on injection than abobotulinumtoxinA reconstituted with preservative-free saline.